UBS Group
BIOA

UBS Group’s BioAmber Inc. BIOA Stock Holding History

UBS Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-99,101
Closed -$40K – 8526
2017
Q4 		$40K Buy
99,101
+75,847
+326% +$36.1K ﹤0.01% 6035
2017
Q3 		$11K Buy
23,254
+20,815
+853% +$24.8K ﹤0.01% 6867
2017
Q2 		$6K Sell
2,439
-3,779
-61% -$8.69K ﹤0.01% 7081
2017
Q1 		$14K Buy
+6,218
New +$23.6K ﹤0.01% 6429
2016
Q1 		– Sell
-1,189
Closed -$7K – 8559
2015
Q4 		$7K Buy
+1,189
New +$8.96K ﹤0.01% 7556
2015
Q3 		– Sell
-310
Closed -$3K – 8854
2015
Q2 		$3K Sell
310
-3,107
-91% -$28.4K ﹤0.01% 8122
2015
Q1 		$30K Buy
3,417
+802
+31% +$7.05K ﹤0.01% 6558
2014
Q4 		$22K Buy
+2,615
New +$23.8K ﹤0.01% 7551

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

UBS Group's BIOA Position: Q1 2018 in Review

UBS Group sold out of BioAmber Inc. (BIOA) in Q1 2018, closing a stake of 99,101 shares — an estimated $40K sold.

UBS Group first reported a position in BIOA in Q4 2014 and held it in 8 quarters. The position peaked at $40K in Q4 2017. 4 funds tracked by Wall St. Rank hold BIOA as of Q1 2018.

  • UBS Group reported no remaining BioAmber Inc. position as of Q1 2018 after selling out during the quarter.
  • UBS Group sold 99,101 BioAmber Inc. shares in Q1 2018, an estimated $40K.
  • UBS Group first reported a position in BioAmber Inc. in Q4 2014 and held it in 8 quarters.
  • UBS Group's BioAmber Inc. position peaked at $40K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2018.

Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.